Stay updated on LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial
Sign up to get notified when there's something new on the LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial page.
Latest updates to the LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial page
- CheckyesterdayChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study, along with the location details.SummaryDifference1%
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe website has added new features while removing extensive details related to participant groups, interventions, and various data fields available for download.SummaryDifference2%
- Check23 days agoChange DetectedSeveral key health-related resources and clinical trial links have been removed, including those from MedlinePlus and NIH, which may impact access to information on mesothelioma and Pembrolizumab.SummaryDifference0.3%
- Check30 days agoChange DetectedThe website has been updated to version 2.12.2, adding several new resources related to mesothelioma and clinical trials, while the previous version 2.12.1 has been removed.SummaryDifference3%
- Check37 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.0%
- Check44 days agoChange DetectedThe website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.SummaryDifference0.1%
Stay in the know with updates to LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial page.